Rel-(1R,3S,5R)-2-(tert-butoxycarbonyl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxylic acid

Catalog No. :
ACMRDT382
CAS No. :
1393537-80-8
Molecular Formula :
C12H19NO4
Molecular Weight :
241.29

IUPAC Name:(1R,3S,5R)-2-(tert-butoxycarbonyl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxylic acid

Rel-(1R,3S,5R)-2-(tert-butoxycarbonyl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$612.00Login to see priceInquiryInquiry
250mg95%$1020.00Login to see priceInquiryInquiry
500mg95%$1457.00Login to see priceInquiryInquiry
1g95%$2082.00Login to see priceInquiryInquiry
5g95%$6245.00Login to see priceInquiryInquiry
10g95%$10408.00Login to see priceInquiryInquiry
25g95%$20815.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRel-(1R,3S,5R)-2-(tert-butoxycarbonyl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxylic acid
IUPAC Name(1R,3S,5R)-2-(tert-butoxycarbonyl)-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxylic acid
Molecular FormulaC12H19NO4
Molecular Weight241.29
SMILESO=C([C@H]1N(C(OC(C)(C)C)=O)[C@]2([H])C[C@]2(C)C1)O
InChI KeyITNAYTUVWAOJPY-SXMVTHIZSA-N
Synonym2-Azabicyclo[3.1.0]hexane-2,3-dicarboxylic acid, 5-methyl-, 2-(1,1-dimethylethyl) ester, (1R,3S,5R)-rel-;rel-(1R,3S,5R)-2-tert-butoxycarbonyl-5-methyl-2-azabicyclo[3.1.0]hexane-3-carboxylic acid
CAS No.1393537-80-8

Synthetic Route by SureRoute

1. ACMRDT382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMRDT382 route product structure diagram
    ACMRDT3821393537-80-8
Inquiry

2. ACMRDT382 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACMRDT382 route product structure diagram
    ACMRDT3821393537-80-8
Inquiry

Comments (0)